RMC No. 101-2020: Publishes the full text of the letter from the Food and Drug Administration of the Department of Health containing the “Addendum to the List of VAT-Exempt Drugs for Hypertension, Diabetes and High Cholesterol” pursuant to RA No. 11467

Files
Download this file

Summary

RMC No. 101-2020 publishes the full text of the Food and Drug Administration letter containing the “Addendum to the List of VAT-Exempt Drugs for Hypertension, Diabetes and High Cholesterol” under RA No. 11467.

Key points

  1. Published list. The Addendum adds to the list of VAT-exempt drugs for hypertension, diabetes and high cholesterol under RA No. 11467. The letter comes from the Food and Drug Administration of the Department of Health.

Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.

Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.